Together these findings demonstrate that endothelial activation of HMOX1 could play an important role in the treatment/prevention of obesity, and further highlight the importance of AMPK-dependent signaling in mediating the anti-obesogenic effects of bilirubin. Here, HMOX1 is linked to obesity due to melanocortin 4 receptor deficiency.